High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers.
about
Reduction of CA125 Levels During Neoadjuvant Chemotherapy Can Predict Cytoreduction to No Visible Residual Disease in Patients with Advanced Epithelial Ovarian Cancer, Primary Carcinoma of Fallopian tube and Peritoneal CarcinomaCaspase 8 expression may determine the survival of women with ovarian cancer.Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.The expression of HtrA2 and its diagnostic value in patients with hepatocellular carcinoma.
P2860
High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
High-temperature-required prot ...... -grade serous ovarian cancers.
@ast
High-temperature-required prot ...... -grade serous ovarian cancers.
@en
type
label
High-temperature-required prot ...... -grade serous ovarian cancers.
@ast
High-temperature-required prot ...... -grade serous ovarian cancers.
@en
prefLabel
High-temperature-required prot ...... -grade serous ovarian cancers.
@ast
High-temperature-required prot ...... -grade serous ovarian cancers.
@en
P2093
P2860
P356
P1476
High-temperature-required prot ...... -grade serous ovarian cancers.
@en
P2093
M Miyamoto
N Shinomiya
P2860
P2888
P304
P356
10.1038/BJC.2015.1
P407
P577
2015-01-27T00:00:00Z